Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin Effects on Renal and Retinal Function in Hypertension and Albuminuria
NCT02376075Phase 3Completed
- Sponsor
- ikfe CRO
- Start
- Jan 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in albuminuria and hypertension (HTN) comparing Linagliptin with Placebo (2 arms). Primary endpoint: Albumin/Creatinine Ratio in 24h urine at 14 weeks. Started Jan 2013; status: completed.
02
Drugs
linagliptin
03
Conditions
albuminuriahypertension (HTN)
Beyond the preview
Go deeper on NCT02376075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02376075.